Literature DB >> 20472797

Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories.

Thomas R Ioerger1, Yicheng Feng, Krishna Ganesula, Xiaohua Chen, Karen M Dobos, Sarah Fortune, William R Jacobs, Valerie Mizrahi, Tanya Parish, Eric Rubin, Chris Sassetti, James C Sacchettini.   

Abstract

The publication of the complete genome sequence for Mycobacterium tuberculosis H37Rv in 1998 has had a great impact on the research community. Nonetheless, it is suspected that genetic differences have arisen in stocks of H37Rv that are maintained in different laboratories. In order to assess the consistency of the genome sequences among H37Rv strains in use and the extent to which they have diverged from the original strain sequenced, we carried out whole-genome sequencing on six strains of H37Rv from different laboratories. Polymorphisms at 73 sites were observed, which were shared among the lab strains, though 72 of these were also shared with H37Ra and are likely to be due to sequencing errors in the original H37Rv reference sequence. An updated H37Rv genome sequence should be valuable to the tuberculosis research community as well as the broader microbial research community. In addition, several polymorphisms unique to individual strains and several shared polymorphisms were identified and shown to be consistent with the known provenance of these strains. Aside from nucleotide substitutions and insertion/deletions, multiple IS6110 transposition events were observed, supporting the theory that they play a significant role in plasticity of the M. tuberculosis genome. This genome-wide catalog of genetic differences can help explain any phenotypic differences that might be found, including a frameshift mutation in the mycocerosic acid synthase gene which causes two of the strains to be deficient in biosynthesis of the surface glycolipid phthiocerol dimycocerosate (PDIM). The resequencing of these six lab strains represents a fortuitous "in vitro evolution" experiment that demonstrates how the M. tuberculosis genome continues to evolve even in a controlled environment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472797      PMCID: PMC2897344          DOI: 10.1128/JB.00166-10

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  46 in total

1.  IS6110 insertions in Mycobacterium tuberculosis: predominantly into coding regions.

Authors:  S Sampson; R Warren; M Richardson; G van der Spuy; P van Helden
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Genome evolution and adaptation in a long-term experiment with Escherichia coli.

Authors:  Jeffrey E Barrick; Dong Su Yu; Sung Ho Yoon; Haeyoung Jeong; Tae Kwang Oh; Dominique Schneider; Richard E Lenski; Jihyun F Kim
Journal:  Nature       Date:  2009-10-18       Impact factor: 49.962

3.  Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region.

Authors:  N E Kurepina; S Sreevatsan; B B Plikaytis; P J Bifani; N D Connell; R J Donnelly; D van Sooligen; J M Musser; B N Kreiswirth
Journal:  Tuber Lung Dis       Date:  1998

4.  Rapid and spontaneous loss of phthiocerol dimycocerosate (PDIM) from Mycobacterium tuberculosis grown in vitro: implications for virulence studies.

Authors:  Pilar Domenech; Michael B Reed
Journal:  Microbiology (Reading)       Date:  2009-08-06       Impact factor: 2.777

5.  Phospholipase region of Mycobacterium tuberculosis is a preferential locus for IS6110 transposition.

Authors:  L Vera-Cabrera; M A Hernández-Vera; O Welsh; W M Johnson; J Castro-Garza
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

6.  Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set.

Authors:  Ingrid Filliol; Alifiya S Motiwala; Magali Cavatore; Weihong Qi; Manzour Hernando Hazbón; Miriam Bobadilla del Valle; Janet Fyfe; Lourdes García-García; Nalin Rastogi; Christophe Sola; Thierry Zozio; Marta Inírida Guerrero; Clara Inés León; Jonathan Crabtree; Sam Angiuoli; Kathleen D Eisenach; Riza Durmaz; Moses L Joloba; Adrian Rendón; José Sifuentes-Osornio; Alfredo Ponce de León; M Donald Cave; Robert Fleischmann; Thomas S Whittam; David Alland
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

7.  Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis.

Authors:  B B Plikaytis; J L Marden; J T Crawford; C L Woodley; W R Butler; T M Shinnick
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  Production of stabilized virulence factor-negative variants by group A streptococci during stationary phase.

Authors:  B A Leonard; M Woischnik; A Podbielski
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  BIOLOGICAL STUDIES OF THE TUBERCLE BACILLUS : III. DISSOCIATION AND PATHOGENICITY OF THE R AND S VARIANTS OF THE HUMAN TUBERCLE BACILLUS (H(37)).

Authors:  W Steenken; W H Oatway; S A Petroff
Journal:  J Exp Med       Date:  1934-09-30       Impact factor: 14.307

View more
  116 in total

1.  Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.

Authors:  Mary A De Groote; Veronica Gruppo; Lisa K Woolhiser; Ian M Orme; Janet C Gilliland; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

3.  N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis.

Authors:  Thulasi Warrier; Kanishk Kapilashrami; Argyrides Argyrou; Thomas R Ioerger; David Little; Kenan C Murphy; Madhumitha Nandakumar; Suna Park; Ben Gold; Jianjie Mi; Tuo Zhang; Eugenia Meiler; Mike Rees; Selin Somersan-Karakaya; Esther Porras-De Francisco; Maria Martinez-Hoyos; Kristin Burns-Huang; Julia Roberts; Yan Ling; Kyu Y Rhee; Alfonso Mendoza-Losana; Minkui Luo; Carl F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

4.  How a Genetically Stable Extremophile Evolves: Modes of Genome Diversification in the Archaeon Sulfolobus acidocaldarius.

Authors:  Dominic Mao; Dennis W Grogan
Journal:  J Bacteriol       Date:  2017-08-08       Impact factor: 3.490

5.  In Vitro Efficacies, ADME, and Pharmacokinetic Properties of Phenoxazine Derivatives Active against Mycobacterium tuberculosis.

Authors:  Lloyd Tanner; Joanna C Evans; Ronnett Seldon; Audrey Jordaan; Digby F Warner; Richard K Haynes; Christopher J Parkinson; Lubbe Wiesner
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

6.  Origins of a 350-kilobase genomic duplication in Mycobacterium tuberculosis and its impact on virulence.

Authors:  Pilar Domenech; Anya Rog; Jalal-ud-din Moolji; Nicolas Radomski; Ashley Fallow; Lizbel Leon-Solis; Julia Bowes; Marcel A Behr; Michael B Reed
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

7.  Genotype of a historic strain of Mycobacterium tuberculosis.

Authors:  Abigail S Bouwman; Sandra L Kennedy; Romy Müller; Richard H Stephens; Malin Holst; Anwen C Caffell; Charlotte A Roberts; Terence A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

8.  Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.

Authors:  Krupa Naran; Atica Moosa; Clifton E Barry; Helena I M Boshoff; Valerie Mizrahi; Digby F Warner
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum.

Authors:  Jean-Philippe Lanoix; Thomas Ioerger; Aimee Ormond; Firat Kaya; James Sacchettini; Véronique Dartois; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

10.  Analysis of mutations in streptomycin-resistant strains reveals a simple and reliable genetic marker for identification of the Mycobacterium tuberculosis Beijing genotype.

Authors:  Cristina Villellas; Liselotte Aristimuño; María-Asunción Vitoria; Cristina Prat; Silvia Blanco; Darío García de Viedma; José Domínguez; Sofía Samper; José A Aínsa
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.